By Nathan Hale ( October 15, 2018, 8:11 PM EDT) -- RxStrategies, a leading program administrator for the federal 340B Drug Pricing Program, renewed its efforts Friday to stop CVS and its in-house administrator Wellpartner from allegedly misappropriating its trade secrets to steal customers, presenting evidence it says refutes several of their defenses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.